Suppr超能文献

脐尿管癌中白蛋白-球蛋白比值的预后意义

Prognostic Significance of Albumin-Globulin Ratio in Urachal Carcinoma.

作者信息

Chen Hengxin, Wu Menghai, Chen Minfeng

机构信息

Department of Urology, Liuzhou Traditional Chinese Medical Hospital, Liuzhou, China,

Department of Urology, Xiangya Hospital Central South University, Changsha, China.

出版信息

Urol Int. 2025;109(1):8-17. doi: 10.1159/000540665. Epub 2024 Sep 27.

Abstract

INTRODUCTION

Although albumin-globulin ratio (AGR) has been used in the prognostic assessment of multiple solid malignancies, so far no research has confirmed the prognostic significance of AGR as a biomarker for urachal carcinoma. We analyzed the relationship between AGR and prognosis in urachal carcinoma, aiming to identify a promising prognostic biomarker for urachal carcinoma.

METHODS

We reviewed the clinical data of 25 patients diagnosed with urachal carcinoma in the Xiangya Hospital, Central South University, from January 2008 to October 2021. The best cut-off value of preoperative AGR was determined according to the receiver operator characteristic curve. The Kaplan-Meier curve was used to analyze the effect of preoperative AGR on the overall survival (OS) and relapse-free survival (RFS) of patients. Cox proportional hazards model was used to analyze prognostic factors including preoperative AGR.

RESULTS

The best cut-off value of preoperative AGR in urachal carcinoma patients is 1.45. Low preoperative AGR is significantly associated with worse OS and RFS. Univariate analysis and multivariate analysis indicated that low preoperative AGR is an independent and reliable factor to predict poor prognosis, OS, and RFS in urachal carcinoma patients.

CONCLUSION

Urachal carcinoma patients with low preoperative AGR have worse prognosis, and preoperative AGR is a valuable prognostic indicator for urachal carcinoma research.

摘要

引言

尽管白蛋白-球蛋白比值(AGR)已用于多种实体恶性肿瘤的预后评估,但迄今为止,尚无研究证实AGR作为脐尿管癌生物标志物的预后意义。我们分析了AGR与脐尿管癌预后之间的关系,旨在确定一种有前景的脐尿管癌预后生物标志物。

方法

我们回顾了2008年1月至2021年10月在中南大学湘雅医院确诊为脐尿管癌的25例患者的临床资料。根据受试者工作特征曲线确定术前AGR的最佳截断值。采用Kaplan-Meier曲线分析术前AGR对患者总生存期(OS)和无复发生存期(RFS)的影响。采用Cox比例风险模型分析包括术前AGR在内的预后因素。

结果

脐尿管癌患者术前AGR的最佳截断值为1.45。术前AGR低与较差的OS和RFS显著相关。单因素分析和多因素分析表明,术前AGR低是预测脐尿管癌患者预后不良、OS和RFS的独立且可靠的因素。

结论

术前AGR低的脐尿管癌患者预后较差,术前AGR是脐尿管癌研究中有价值的预后指标。

相似文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验